Answer
It can be associated with fast or irregular heart rhythms and QT prolongation, sometimes alongside cytokine release syndrome. ECG and electrolyte monitoring are used where indicated.
Sources for this answer
- KIMMTRAK (tebentafusp) 200 micrograms/ mL concentrate for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.